ATLASBiogen (BIIB) Q3 2026 earnings results
Biogen (BIIB) reported EPS of $2.62 against an analyst estimate of $2.06: a beat of $0.56 (27.2%). The quarter ended Sep 30, 2026; the company reported on Wednesday, October 28, 2026, before the open.
Status: Confirmed · cross-checked Nov 2 · Source: EODHD (calendar and fundamentals, cross-checked)
Notify me when Biogen reports
Track BIIB free Add Biogen to a free ATLAS watchlist.
BIIB Q3 2026 results at a glance
| EPS reported | $2.62 |
|---|---|
| EPS estimate | $2.06 |
| Surprise | Beat · +$0.56 (+27.2%) |
| Quarter ended | Sep 30, 2026 |
| Reported | Oct 28, 2026, before the open |
| Status | Confirmed · cross-checked Nov 2 |
EPS is as supplied by EODHD, in US dollars per share; whether it is adjusted or GAAP follows that source. This is Biogen’s Q3 2026, a calendar-year company.
Biogen EPS surprise history: last 5 quarters
Biogen beat the EPS estimate in 5 of its last 5 reports, with an average surprise of +34.5%.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Oct 28, 2026 | $2.06 | $2.62 | +27.2% | Beat | – |
| Jul 29, 2026 | $2.03 | $3.60 | +77.3% | Beat | +1.1% |
| Apr 29, 2026 | $2.95 | $3.57 | +21.0% | Beat | +3.2% |
| Feb 6, 2026 | $1.62 | $1.99 | +22.8% | Beat | +4.6% |
| Oct 30, 2025 | $3.88 | $4.81 | +24.0% | Beat | +4.3% |
*Move: change in the closing price from the last close before the report day to the close the day after it. It is filled in a few trading days after each report.
BIIB stock reaction to the report
BIIB moved -3.43% in the first session that reflects the report (close of Oct 27, 2026 $252.73 to close of Oct 28, 2026 $244.05). Since the report: -1.49% (latest close $248.96 on Nov 2, 2026, against $252.73 before the reaction).
Next BIIB earnings report
Biogen has not announced its next earnings date yet. This page shows a date only once it is confirmed. See the BIIB earnings calendar.
ATLAS fair value and signal for BIIB
| Last price | $252.20 (-0.6%) |
|---|---|
| ATLAS fair value | $183.87 (range $120.78–$279.91) · price is 37% above it |
| Chance of a higher close in 1 month | 51% (normal range $239.06–$266.90) |
These are model outputs from the same valuation and calibrated model as the Biogen stock page. They describe an ordinary period and are not a forecast of any particular outcome.
Biogen Q3 2026 earnings: frequently asked questions
Did Biogen beat earnings estimates for Q3 2026?
Biogen reported EPS of $2.62 against an analyst estimate of $2.06: a beat of $0.56 (27.2%).
When did Biogen report Q3 2026 results?
Biogen reported on Wednesday, October 28, 2026, before the open, for the quarter ended Wednesday, September 30, 2026.
How often does BIIB beat EPS estimates?
In its last 5 reports with a recorded result, Biogen beat the EPS estimate 5 times; the average surprise was +34.5%. Past results do not predict the next one.
How does ATLAS confirm a result?
A result is published only after it is cross-checked: the EODHD earnings calendar and the EODHD fundamentals feed must show the same EPS for the same fiscal period, or the same value must appear in two consecutive checks. Unconfirmed figures are never published. If the figures are revised later, this page updates.
Educational information, not investment advice. Disclaimer